PRIA Logo™
119-hr-10597119th CongressWALLET

Affordability is Access Act of 2026

Sponsored By: Representative Pressley, Ayanna [D-MA-7]

Introduced

Summary

**This bill would guarantee that *free coverage for FDA‑approved over‑the‑counter contraceptives* is included in group and individual health plans.** It would eliminate cost sharing for OTC birth control and direct federal agencies to align coverage rules with FDA approvals while protecting stronger state laws.

Show full summary
  • Families and contraceptive users would be able to get FDA‑approved OTC contraceptives without a prescription and without copays or other cost sharing, making short‑term access easier.
  • People who rely on prescription birth control would see plans required to cover prescription contraceptives, but when multiple therapeutically equivalent products exist plans may cover only one option.
  • Employers and insurers would have to add OTC contraceptives to plan coverage and follow new agency guidance tying coverage to FDA OTC status.
  • Retailers would be barred from blocking access to OTC contraceptives or accurate medical information, though they could still decline a sale when a buyer cannot pay.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

No-cost OTC birth control, limited prescriptions

If enacted, this bill would require many group and individual health plans to cover FDA‑approved over‑the‑counter birth control with no out‑of‑pocket cost. You would not need a prescription to get that coverage. At the same time, plans would be allowed to meet their prescription contraceptive requirement by covering only one product when there are therapeutically equivalent prescription options. These rules would take effect upon enactment.

Retail access and regulatory protections

If enacted, this bill would bar retailers that stock FDA‑approved OTC contraceptives from interfering with a person's purchase or access to accurate medical information about those products. A retailer could still refuse to provide the product if the person cannot pay directly, through insurance, or by another payment method. The bill would also say it does not change how the FDA reviews or approves non‑prescription drugs and does not block stronger state or federal consumer protections.

Sponsors & CoSponsors

Sponsor

Pressley, Ayanna [D-MA-7]

MA • D

Cosponsors

  • Rep. McClellan, Jennifer L. [D-VA-4]

    VA • D

    Sponsored 9/24/2026

  • Rep. McIver, LaMonica [D-NJ-10]

    NJ • D

    Sponsored 9/24/2026

  • Rep. Meng, Grace [D-NY-6]

    NY • D

    Sponsored 9/24/2026

  • Rep. Mullin, Kevin [D-CA-15]

    CA • D

    Sponsored 9/24/2026

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 9/24/2026

  • Rep. Pingree, Chellie [D-ME-1]

    ME • D

    Sponsored 9/24/2026

  • Rep. Quigley, Mike [D-IL-5]

    IL • D

    Sponsored 9/24/2026

  • Rep. Scanlon, Mary Gay [D-PA-5]

    PA • D

    Sponsored 9/24/2026

  • Rep. Stansbury, Melanie A. [D-NM-1]

    NM • D

    Sponsored 9/24/2026

  • Rep. Tlaib, Rashida [D-MI-12]

    MI • D

    Sponsored 9/24/2026

  • Rep. Tokuda, Jill N. [D-HI-2]

    HI • D

    Sponsored 9/24/2026

  • Rep. Torres, Ritchie [D-NY-15]

    NY • D

    Sponsored 9/24/2026

  • Rep. Underwood, Lauren [D-IL-14]

    IL • D

    Sponsored 9/24/2026

  • Rep. Watson Coleman, Bonnie [D-NJ-12]

    NJ • D

    Sponsored 9/24/2026

  • Rep. Williams, Nikema [D-GA-5]

    GA • D

    Sponsored 9/24/2026

  • Rep. Wilson, Frederica S. [D-FL-24]

    FL • D

    Sponsored 9/24/2026

  • Rep. DeLauro, Rosa L. [D-CT-3]

    CT • D

    Sponsored 9/28/2026

  • Rep. Frankel, Lois [D-FL-22]

    FL • D

    Sponsored 9/28/2026

  • Rep. Randall, Emily [D-WA-6]

    WA • D

    Sponsored 9/28/2026

  • Rep. Lofgren, Zoe [D-CA-18]

    CA • D

    Sponsored 9/28/2026

  • Rep. Takano, Mark [D-CA-39]

    CA • D

    Sponsored 10/6/2026

  • Rep. Cisneros, Gilbert Ray [D-CA-31]

    CA • D

    Sponsored 10/6/2026

  • Rep. Bera, Ami [D-CA-6]

    CA • D

    Sponsored 9/24/2026

  • Rep. Ocasio-Cortez, Alexandria [D-NY-14]

    NY • D

    Sponsored 9/24/2026

  • Rep. Barragán, Nanette Diaz [D-CA-44]

    CA • D

    Sponsored 9/24/2026

  • Rep. Brown, Shontel M. [D-OH-11]

    OH • D

    Sponsored 9/24/2026

  • Rep. Brownley, Julia [D-CA-26]

    CA • D

    Sponsored 9/24/2026

  • Rep. Carbajal, Salud O. [D-CA-24]

    CA • D

    Sponsored 9/24/2026

  • Rep. Carter, Troy A. [D-LA-2]

    LA • D

    Sponsored 9/24/2026

  • Rep. Casten, Sean [D-IL-6]

    IL • D

    Sponsored 9/24/2026

  • Rep. Chu, Judy [D-CA-28]

    CA • D

    Sponsored 9/24/2026

  • Rep. Clarke, Yvette D. [D-NY-9]

    NY • D

    Sponsored 9/24/2026

  • Rep. Conaway, Herbert C. [D-NJ-3]

    NJ • D

    Sponsored 9/24/2026

  • Rep. Crockett, Jasmine [D-TX-30]

    TX • D

    Sponsored 9/24/2026

  • Rep. Friedman, Laura [D-CA-30]

    CA • D

    Sponsored 9/24/2026

  • Rep. García, Jesús G. "Chuy" [D-IL-4]

    IL • D

    Sponsored 9/24/2026

  • Rep. Goldman, Daniel S. [D-NY-10]

    NY • D

    Sponsored 9/24/2026

  • Rep. Gomez, Jimmy [D-CA-34]

    CA • D

    Sponsored 9/24/2026

  • Rep. Johnson, Henry C. "Hank" [D-GA-4]

    GA • D

    Sponsored 9/24/2026

  • Rep. Lee, Summer L. [D-PA-12]

    PA • D

    Sponsored 9/24/2026

  • Rep. McGovern, James P. [D-MA-2]

    MA • D

    Sponsored 10/29/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation